Retinoblastoma protein expression in endometrial hyperplasia and carcinoma

Gynecologic Oncology

Volumn 65, Issue 2, 1997, Pages 232-236

  Niemann, Theodore H ^a   Yilmaz, Asli G ^a   McGaughy, Violeta R ^a   Vaccarello, Luis ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOGENESIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS REGULATION;

EID: 0031148989     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4664     Document Type: Article

References (25)

1. Parker S L, Tong T, Bolden S, Wingo P A. Cancer statistics, 1996. CA Cancer J Clin. 46:1996;5-27.
2. Xu H-J. Altered retinoblastoma (RB) protein expression in human malignancies. Adv Anat Pathol. 2:1995;213-226.
3. Ishikawa J, Xu H-J, Hu S-X, Yandell D W, Maeda S, Kamidono S, Benedict W F, Takahashi R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res. 51:1991;5736-5743.
4. Presti J C, Reuter V E, Galan T, Fair W R, Cordon-Carso C. Molecular genetic alterations in superfical and locally advanced bladder cancer. Cancer Res. 51:1991;5405-5409.
5. Yokota J, Akiyama T, Fung Y-K T. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene. 3:1988;471-473.
6. Xu H-J, Hu S-X, Cagle P T, Moore G E, Benedict W F. Absence of retinoblastoma-protein expression in primary non-small cell lung carcinomas. Cancer Res. 51:1991;2735-2739.
7. Lee E Y-HP, To H, Shew J-Y, Bookstein R, Scully P, Lee W-H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science. 241:1988;218-221.
8. Bookstein R, Rio P, Madreperla S A. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA. 87:1990;7762-7766.
9. Zhang X, Xu H-J, Murahami Y, Sachse R, Yashima K, Hirohashi S, Hu S-X, Benedict W F, Sekiya T. Deletions of chromosome 13q mutations in RB1 and RB protein state, in human hepatocellular carcinoma. Cancer Res. 54:1994;4177-4182.
10. Enomoto T, Fujita M, Inoue M, Nakazawa-Miyamoto A, Tanizawa O, Nomura T. Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma. Mol Carcinogen. 8:1993;132-137.
11. R, E, Scully, T, A, Bonfiglio, R, J, Kurman, S, G, Silverberg, E, J, Wilkinson, 1994, Histological Typing of Female Genital Tract Tumours, Springer Verlag, New York.
12. Gynecol Oncol. 35:1989;125-127.
13. Geradts J, Hu S-X, Lincoln C E, Benedict W F, Xu H-J. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer. 58:1994;161-167.
14. Geradts J, Kratzke R A, Crush-Stanton S, Wen S F, Lincoln C E. Wild-type and mutant retinoblastoma protein in oaraffin sections. Mod Pathol. 9:1996;339-347.
15. Shimizu E, Coxon A, Otterson G A, Steinberg S M, Kratzke R A, Kim Y W, Fedorko J, Oie H, Johnson B E, Mulshine J L, Minna J D, Gazdar A F, Kaye F J. RB protein status and clinical correltation from 171 cell lines representing lung cancer, extrapulomonary small cell carcinoma, and mesothelioma. Oncogene. 9:1994;2441.
16. Kaye F J, Kratzke R A, Gerster J L, Horowitz J M. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA. 87:1990;6922.
17. Murphree A L, Benedict W F. Retinoblastoma: clues for human oncogenesis. Science. 223:1984;1028-1033.
18. Friend S H, Bernards R, Rogelj S, Weinberg R A, Rapaport J M, Albert D M, Dryja T P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
19. Fung Y-K T, Murphree A L, T'Ang A, Qian J, Hinrichs S H, Benedict W F. Structural evidence for the authenticity of the human retinoblastoma gene. Science. 236:1987;1657-1661.
20. Sasano H, Comerford J, Silverberg S G, Garrett CT C T. An analysis of abnormalities of the retinoblastoma gene in human ovarian and endometrial carcinoma. Cancer. 66:1990;2150-2154.
21. Ambros R A, Vigna P A, Figge J, Kallakury B VS, Mastrangelo A, Eastamn A Y, Malfetano J, Figge H L, Ross J S. Observations on tumor and metastatic gene status in endometrial carcinoma with particular emphasis on p53. Cancer. 73:1994;1686-1692.
22. Li S-F, Shiozawa T, Nakayama K, Nikaido T, Fujii S. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer. 77:1996;321-329.
23. Cordon-Cardo C, Richon V M. Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol. 144:1994;500-510.
24. Xu H-J, Hu S-X, Benedict W F. Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene. 6:1991;1139-1144.
25. Taylor R R, Linnoila R I, Gerardts J, Teneriello M G, Nash J D, Park R C, Birrer M J. Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations. Gynecol Oncol. 58:1995;307-311.